Nuvectis Pharma, Inc.

NASDAQ:NVCT

Biotechnology

Healthcare
$19.84 +3.06%

+$0.39 today

Market cap
$682.28M
Beta
-0.07
P/E (TTM)
-11.2
EPS (TTM)
-$1.16
52W Low $5.55High $13.51

Volume 0.16M

Average 0.08M

Price history

Nuvectis Pharma, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+237.41%

Period high

$28.53

Period low

$5.81

Latest

$19.84

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
EFFECTAug 28, 2026Aug 31, 2026
S-3Aug 21, 2026Aug 21, 2026
8-KAug 21, 2026Aug 21, 2026
SC 13GAug 6, 2026Aug 6, 2026
4Aug 5, 2026Aug 5, 2026
8-KAug 4, 2026Aug 4, 2026
10-QAug 4, 2026Aug 4, 2026
4Jul 1, 2026Jul 1, 2026
4Jul 1, 2026Jul 1, 2026
8-KJun 30, 2026Jun 30, 2026
424B5Jun 30, 2026Jun 30, 2026
8-KJun 29, 2026Jun 29, 2026
424B5Jun 29, 2026Jun 29, 2026

Competitors

Who does Nuvectis Pharma, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about NVCT's filings, answered from its disclosures.

What is the latest NVCT filing?

The latest filing shown is 8-K dated Nov 4, 2026.

How many recent filings does NVCT have?

Intrinsic Alpha currently shows 20 recent filings for NVCT.